Back to Rankings

COLL

Collegium PharmaceuticalB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
COLL vs peer average
77/100
COLL vs. peer average (B vs. D)
Grade spread
A 1 · B 1 · C 1 · D 3 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

CRVS is the first available peer comparator.

Same-sector smaller-cap biotech with a similar market value but much earlier commercial maturity; mostly a sentiment and valuation comparator, not an operating comp.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCRVSCorvus
COLL
Collegium Pharmaceutical
CRVS
Corvus
Grade
B
D
Momentum
17
10
Value
72
41
Sentiment
87
83
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs CRVS

COLL / CRVS
Grade Position
Above peers
COLL vs. peer average (B vs. D)
77/100
Momentum
17
COLL
Value
72
COLL
Sentiment
87
COLL

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs COLL
1
CRVS
CRVS
D
40/100
+2
2
EYPT
EYPT
C
60/100
+1
3
MNKD
MNKD
A
100/100
-1
4
AKTS
Aktis Oncology Inc Common
N/A
-
-
5
IVA
Inventiva SA ADR
F
20/100
+3
CRVS is the first peer returned for this comparison set.